M/s Zydus Cadila

Healthcare

DBT-BIRAC supported indigenously developed DNA Vaccine Candidate by Zydus Cadila, approved for Phase III clinical trials

SMEDesk - January 4, 2021

The Nation’s first indigenously developed DNA vaccine candidate against COVID-19, ZyCoV-D, by M/s Zydus Cadila has been approved by Drugs Controller General of India (DCGI), for conduct of the Phase III clinical trials. The candidate has been supported by...

- Advertisement -

spot_img

Latest News

WomenpreneursSMEDesk - June 10, 2026

Reimagining HRTech: Sonali Chowdhry on Building Scalable, People-First Workforce Solutions

As organizations navigate rapid digital transformation, the need for intelligent, integrated, and people-centric HR systems has never been more...

- Advertisement -

spot_img

Tech Gyaan

Zourney.in Bets on AI To Simplify India’s B2B Travel

SMEDesk - June 1, 2026

Womenpreneurs

Crafting Stories with Purpose: The Visionary Journey of Vidula Kanitkar Kothare

SMEDesk - May 21, 2026

Skill Development

MSME Ministry Trains 2,500 Artisans in AI Under PM Vishwakarma Scheme

SMEDesk - April 21, 2026

Industry

MeitY Selects 10 AI Startups for Global Acceleration Programme

SMEDesk - April 21, 2026